Prime Capital Investment Advisors, LLC
Position in GNLX — GENELUX Corp
CIK 1731446
OVERLAND PARK, KS
Position in GNLX
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$47,904
New position
Shares Held
15,915
first reported quarter
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 72 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Prime Capital Investment Advisors, LLC holds $15,655,242 across 20 Biotechnology names. GNLX ranks #13 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16,572 | $10,333,304 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,898 | $1,439,523 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
15,336 | $1,250,037 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
11,483 | $447,951 | |
| 5 | IMTX |
Immatics N.V.
|
40,000 | $405,200 | |
| 6 | MRNA |
Moderna, Inc.
|
4,985 | $349,099 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
3,938 | $312,244 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
1,558 | $291,782 |
All Filings in GNLX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $47,904 | 15,915 | Shares | Sole | 2026-08-05 | |
| No filing history on record for this holder in this stock. | ||||||